UPDATE 1-Hikma to replace Inmarsat in FTSE 100 index

miércoles 1 de junio de 2016 13:48 GYT

* Hikma to replace Inmarsat in FTSE 100

* Metro Bank, CYBG, CMC Markets to be added in FTSE 250

* Jimmy Choo, Melrose, Ophir Energy to leave FTSE 250

By Atul Prakash

LONDON, June 1 (Reuters) - Hikma Pharmaceuticals will be promoted to Britain's blue chip FTSE 100 equity index following a sharp rally in its shares since March, while satellite firm Inmarsat will drop out of the index.

The London Stock Exchange Group said on Wednesday that the changes will take effect on June 20.

Getting into the FTSE 100 can often fuel further demand for a company's shares, since funds that track the FTSE or invest in the index can then add that stock to their portfolio, while the inverse is true if a company falls out of the FTSE 100.

Shares in Hikma, which reiterated its guidance for 2016 last month and said it continued to expect full year group revenue in the range of $2.0 billion to $2.1 billion, have surged 45 percent since mid-March.

On the other hand, Inmarsat has fallen 37 percent since early February as the company is facing tough trading conditions in its maritime and government markets businesses.   Continuación...